5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic SurgeryPostoperative Ocular Inflammation; Postoperative Ocular PainEnrolling by invitationPhase 32026-09-22NCT07832552
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland DysfunctionMeibomian Gland Dysfunction, dry eye syndrome, eye disorder, eyelid disorder, lacrimal apparatus disorderRecruitingPhase 42026-06-09NCT07224529
Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeksdry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 42026-06-03NCT07368595
Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Studydry eye syndrome, eye disorder, lacrimal apparatus disorderRecruitingNot stated2026-05-05NCT07566975
Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsDiabetes Complications, Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorderEnrolling by invitationPhase 42026-04-07NCT07456826